Aire
Showing 26 - 50 of 233
SARS-Associated Coronavirus, Covid19, SARS-CoV Infection Trial in Ciudad Autonoma de Buenos Aire (Convalescent plasma)
Completed
- SARS-Associated Coronavirus
- +2 more
- Convalescent plasma
-
Ciudad Autonoma de Buenos Aire, ArgentinaHospital Francisco Javier Muñiz
Aug 23, 2021
Bloody Diarrhea, STEC, Unspecified, Hemolytic-Uremic Syndrome Trial in Argentina (INM004, Placebo)
Suspended
- Bloody Diarrhea
- +3 more
- INM004
- Placebo
-
Bahia Blanca, Buenos Aires, Argentina
- +6 more
Mar 28, 2022
Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Obesity
- Overweight
- Tirzepatide
- Placebo
-
Huntington Park, California
- +64 more
Mar 22, 2022
Disease Activity and Adverse Events of Upadacitinib in Adult
Recruiting
- Ulcerative Colitis
-
Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, Argentina
- +13 more
Aug 16, 2022
Diabetes, Type 2, Diabetes, Mental Health Trial in United States (Empathy in Action for life with diabetes., Control Phase 2
Enrolling by invitation
- Diabetes Mellitus, Type 2
- +3 more
- Empathy in Action for life with diabetes.
- Control Phase 2 Materials Only
-
Austin, Texas
- +8 more
May 25, 2022
COVID-19 Vaccines Trial in Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aires (Gam-COVID-Vac / Gam-COVID-Vac)
Recruiting
- COVID-19 Vaccines
- Gam-COVID-Vac / Gam-COVID-Vac
-
Ciudad Autonoma de Buenos Aire, CBA, Argentina
- +1 more
Jul 28, 2021
Rheumatoid Arthritis Trial in Worldwide (LY3871801, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- LY3871801
- Placebo
-
Woodland Hills, California
- +46 more
May 10, 2023
Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Type 2 Diabetes
- +2 more
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +74 more
Apr 18, 2022
Type 1 Diabetes, Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Not yet recruiting
- Type 1 Diabetes
- Diabetes
- LY3209590
- Insulin Degludec
-
Concord, California
- +86 more
Aug 17, 2022
Healthy Trial in Ciudad Autónoma de Buenos Aire (Neo-Russian, Aussie, RBS)
Completed
- Healthy
- Neo-Russian
- +2 more
-
Ciudad Autónoma de Buenos Aire, Caba, ArgentinaOscar Ronzio
Feb 11, 2021
Personal Protective Equipment, Self Contamination Trial in Ciudad Autonoma de Buenos Aire (Gown personal protective equipment
Completed
- Personal Protective Equipment
- Self Contamination
- Gown personal protective equipment (PPE-G) suit
- Coverall personal protective equipment (PPE-C) suit
-
Ciudad Autonoma de Buenos Aire, Buenos Aires, ArgentinaHospital Italiano de Buenos Aires
Feb 18, 2021
Cataract Trial in Ciudad Autonoma de Buenos Aire (Difluprednate Ophthalmic Emulsion 0.05%, Prednisolone Acetate 1% Phenylephrine
Completed
- Cataract
- Difluprednate Ophthalmic Emulsion 0.05%
- Prednisolone Acetate 1% Phenylephrine hydrochloride 0,12% ophthalmic solution
-
Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, ArgentinaLaboratorios Poen
Mar 29, 2021
Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Obesity
- Cardiovascular Diseases
- Retatrutide
- Placebo
-
Phoenix, Arizona
- +165 more
May 22, 2023
Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax)
Completed
- Chronic Lymphocytic Leukemia (CLL)
-
La Plata, Buenos Aires, Argentina
- +32 more
Feb 10, 2022
Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Active, not recruiting
- Type 2 Diabetes
- LY3209590
- Insulin Degludec
-
Little Rock, Arkansas
- +129 more
Jan 19, 2023
Obesity, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (Tirzepatide, Placebo)
Recruiting
- Obesity
- Heart Failure With Preserved Ejection Fraction
- Tirzepatide
- Placebo
-
Huntsville, Alabama
- +144 more
Jan 18, 2023
Hereditary Angioedema (HAE) Trial in Worldwide (Lanadelumab)
Available
- Hereditary Angioedema (HAE)
- Angioedema
- Lanadelumab 150 mg
- Lanadelumab 300 mg
-
Scottsdale, Arizona
- +19 more
Sep 16, 2022
SARS Virus, SARS-CoV-2, COVID-19 Trial in Ciudad Autonoma de Buenos Aire (Convalescent SARS COVID-19 plasma, Placebo)
Completed
- SARS Virus
- +2 more
- Convalescent SARS COVID-19 plasma
- Placebo
-
Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, ArgentinaHospital Italiano de Buenos Aires
Sep 29, 2020
Safety, and Effectiveness of Oral Upadacitinib in Adult and
Recruiting
- Atopic Dermatitis
-
Pilar, Buenos Aires, Argentina
- +103 more
Jan 25, 2023
Idiopathic Pulmonary Fibrosis Trial in United States (Placebo, Pirfenidone, Deupirfenidone)
Recruiting
- Idiopathic Pulmonary Fibrosis
- Placebo
- +2 more
-
Birmingham, Alabama
- +39 more
Dec 20, 2022
Fungal Origins in Autoimmune Polyendocrinopathy of Type 1
Recruiting
- Polyendocrinopathies, Autoimmune
-
Lille, FranceHop Claude Huriez Chu Lille
Feb 15, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Degludec)
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Insulin Degludec
-
Little Rock, Arkansas
- +121 more
Jan 14, 2022